119 related articles for article (PubMed ID: 29090522)
1. PDCD1 gene polymorphisms as regulators of T-lymphocyte activity in cutaneous melanoma risk and prognosis.
Gomez GVB; Rinck-Junior JA; Oliveira C; Silva DHL; Mamoni RL; Lourenço GJ; Moraes AM; Lima CSP
Pigment Cell Melanoma Res; 2018 Mar; 31(2):308-317. PubMed ID: 29090522
[TBL] [Abstract][Full Text] [Related]
2. Programmed cell death 1 (PDCD1) gene haplotypes and susceptibility of patients to basal cell carcinoma.
Fathi F; Zamani B; Piroozmand A; Mozafarpoor S; Seyedhashemi E; ArefNezhad R; Motedayyen H
Mol Biol Rep; 2021 Mar; 48(3):2047-2052. PubMed ID: 33389528
[TBL] [Abstract][Full Text] [Related]
3. Effects of the programmed cell death 1 (PDCD1) polymorphisms in susceptibility to systemic lupus erythematosus.
Fathi F; Sadeghi E; Lotfi N; Hafezi H; Ahmadi M; Mozafarpoor S; Motedayyen H
Int J Immunogenet; 2020 Feb; 47(1):57-64. PubMed ID: 31565862
[TBL] [Abstract][Full Text] [Related]
4. Association of programmed death-1 gene polymorphisms with the risk of basal cell carcinoma.
Fathi F; Ebrahimi M; Eslami A; Hafezi H; Eskandari N; Motedayyen H
Int J Immunogenet; 2019 Dec; 46(6):444-450. PubMed ID: 31293069
[TBL] [Abstract][Full Text] [Related]
5. PD1.5 variant on
Gomez GVB; Longhi LNA; Saito HPA; Lourenço GJ; Dos Reis RB; Tobias Machado M; Reis LO; Denardi F; Lima CSP
Am J Clin Exp Urol; 2022; 10(5):334-340. PubMed ID: 36313211
[TBL] [Abstract][Full Text] [Related]
6.
Parakh S; Musafer A; Paessler S; Witkowski T; Suen CSNLW; Tutuka CSA; Carlino MS; Menzies AM; Scolyer RA; Cebon J; Dobrovic A; Long GV; Klein O; Behren A
Front Immunol; 2021; 12():672521. PubMed ID: 34177913
[TBL] [Abstract][Full Text] [Related]
7. Association between PDCD1 Gene Polymorphisms and Risk of Systemic Lupus Erythematosus in Three Main Ethnic Groups of the Malaysian Population.
Chua KH; Lian LH; Sim XJ; Cheah TE; Lau TP
Int J Mol Sci; 2015 Apr; 16(5):9794-803. PubMed ID: 25938972
[TBL] [Abstract][Full Text] [Related]
8. PDCD1 and CTLA4 polymorphisms affect the susceptibility to, and clinical features of, chronic immune thrombocytopenia.
Kasamatsu T; Ino R; Takahashi N; Gotoh N; Minato Y; Takizawa M; Yokohama A; Handa H; Saitoh T; Tsukamoto N; Murakami H
Br J Haematol; 2018 Mar; 180(5):705-714. PubMed ID: 29359792
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of programmed cell death 1 polymorphisms with systemic lupus erythematosus risk.
Gao J; Gai N; Wang L; Liu K; Liu XH; Wei LT; Tian T; Li SL; Zheng Y; Deng YJ; Dai ZJ; Fu RG
Oncotarget; 2017 May; 8(22):36885-36897. PubMed ID: 28415570
[TBL] [Abstract][Full Text] [Related]
10. Association between PDCD1 gene polymorphisms and psoriasis susceptibility in the Chinese population.
Hua S; Fan B; Mao W; Xu R; Wang Y; Kuai L; Ding X; Li B; Chen J; Miao X
Int J Dermatol; 2021 Nov; 60(11):1411-1417. PubMed ID: 34057203
[TBL] [Abstract][Full Text] [Related]
11. PDCD1 polymorphism amplifies the predisposing effect conferred by CTLA4 polymorphism in chronic hepatitis B virus infection.
Zhang G; Han Q; Duan S; Li Z; Li N; Zhu Q; Chen J; Lv Y; Zeng X; Chen Y; Liu Z
Hum Immunol; 2012 Apr; 73(4):421-5. PubMed ID: 22342451
[TBL] [Abstract][Full Text] [Related]
12. Inherited variations in human pigmentation-related genes modulate cutaneous melanoma risk and clinicopathological features in Brazilian population.
Lourenço GJ; Oliveira C; Carvalho BS; Torricelli C; Silva JK; Gomez GVB; Rinck-Junior JA; Oliveira WL; Vazquez VL; Serrano SV; Moraes AM; Lima CSP
Sci Rep; 2020 Jul; 10(1):12129. PubMed ID: 32699307
[TBL] [Abstract][Full Text] [Related]
13. Influence of IL1B (rs16944) and IL1R2 (rs4141134) polymorphisms on aggressiveness and prognosis of cutaneous melanoma.
Torricelli C; Carron J; Carvalho BF; Macedo LT; Rinck-Junior JA; Lima CSP; Lourenço GJ
Melanoma Res; 2021 Oct; 31(5):476-481. PubMed ID: 34284461
[TBL] [Abstract][Full Text] [Related]
14. Altered TNF-α and IFN-γ levels associated with PD1 but not TNFA polymorphisms in patients with chronic HBV infection.
Zhang G; Li Z; Han Q; Li N; Zhu Q; Li F; Lv Y; Chen J; Lou S; Liu Z
Infect Genet Evol; 2011 Oct; 11(7):1624-30. PubMed ID: 21712100
[TBL] [Abstract][Full Text] [Related]
15. Lack of association of programmed cell death 1 gene (PDCD1) polymorphisms with susceptibility to chronic urticaria in patients with positive autologous serum skin test.
Brzoza Z; Grzeszczak W; Trautsolt W; Moczulski D
J Investig Allergol Clin Immunol; 2012; 22(6):432-6. PubMed ID: 23101188
[TBL] [Abstract][Full Text] [Related]
16. XPC (A2920C), XPF (T30028C), TP53 (Arg72Pro), and GSTP1 (Ile105Val) polymorphisms in prognosis of cutaneous melanoma.
Gomez GV; de Oliveira C; Rinck-Junior JA; de Moraes AM; Lourenço GJ; Lima CS
Tumour Biol; 2016 Mar; 37(3):3163-71. PubMed ID: 26427666
[TBL] [Abstract][Full Text] [Related]
17. PDCD1 and PDCD1LG1 polymorphisms affect the susceptibility to multiple myeloma.
Kasamatsu T; Awata M; Ishihara R; Murakami Y; Gotoh N; Matsumoto M; Sawamura M; Yokohama A; Handa H; Tsukamoto N; Saitoh T; Murakami H
Clin Exp Med; 2020 Feb; 20(1):51-62. PubMed ID: 31620907
[TBL] [Abstract][Full Text] [Related]
18. PDCD1 single nucleotide genes polymorphisms confer susceptibility to juvenile-onset systemic lupus erythematosus.
Mahmoudi M; Rezaiemanesh A; Salmaninejad A; Harsini S; Poursani S; Bahrami T; Tahghighi F; Ziaee V; Rezaei N
Autoimmunity; 2015; 48(7):488-93. PubMed ID: 26108738
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous adverse events of anti-programmed death 1 antibodies combined with anti-cytotoxic T-lymphocyte-associated protein 4 therapy use in patients with metastatic melanoma.
Hwang SJE; Park JJW; Wakade D; Chou S; Byth K; Fernandez-Penas P
Melanoma Res; 2019 Apr; 29(2):172-177. PubMed ID: 30273233
[TBL] [Abstract][Full Text] [Related]
20. Genetic variants in the integrin signaling pathway genes predict cutaneous melanoma survival.
Li H; Wang Y; Liu H; Shi Q; Xu Y; Wu W; Zhu D; Amos CI; Fang S; Lee JE; Han J; Wei Q
Int J Cancer; 2017 Mar; 140(6):1270-1279. PubMed ID: 27914105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
